Mature human eosinophils have the capacity to express HLA-DR
- PMID: 2919183
- PMCID: PMC286687
- DOI: 10.1073/pnas.86.4.1348
Mature human eosinophils have the capacity to express HLA-DR
Abstract
Human eosinophils are known to lose Ia antigen expression as they mature, and, accordingly, eosinophils obtained from the blood of five eosinophilic donors and three of four normal donors failed to display the major histocompatibility complex class II antigen HLA-DR, as determined by flow cytometry. However, when eosinophils from these nine donors were maintained in culture with recombinant human granulocyte-macrophage colony-stimulating factor and murine 3T3 fibroblasts, HLA-DR consistently developed on the eosinophils. By days 4-6 of culture, 24-97% of eosinophils were HLA-DR+, and the eosinophils remained morphologically mature. In contrast, another class II antigen, HLA-DQ, was not detectable by flow cytometry on eosinophils from eight of nine donors. Cultured eosinophils were able to synthesize HLA-DR, as documented by the incorporation of [35S]methionine into immunoprecipitable HLA-DR heavy and light chains. These findings show that mature eosinophils can synthesize and express HLA-DR and provide a means whereby eosinophils may interact with CD4+ lymphocytes.
Similar articles
-
Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia.J Allergy Clin Immunol. 1993 Sep;92(3):442-9. doi: 10.1016/0091-6749(93)90123-w. J Allergy Clin Immunol. 1993. PMID: 8360395 Review.
-
Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils.Blood. 1994 Oct 15;84(8):2733-40. Blood. 1994. PMID: 7919386
-
Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression.J Immunol. 1993 Mar 15;150(6):2554-62. J Immunol. 1993. PMID: 8450230
-
Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.Immunology. 1994 Apr;81(4):584-91. Immunology. 1994. PMID: 7518797 Free PMC article.
-
Eosinophils and cytokines.Agents Actions Suppl. 1993;43:197-208. doi: 10.1007/978-3-0348-7324-6_17. Agents Actions Suppl. 1993. PMID: 8368163 Review.
Cited by
-
Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".J Allergy Clin Immunol. 2012 Sep;130(3):572-84. doi: 10.1016/j.jaci.2012.07.025. J Allergy Clin Immunol. 2012. PMID: 22935586 Free PMC article. Review.
-
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes.J Exp Med. 1999 Aug 16;190(4):487-95. doi: 10.1084/jem.190.4.487. J Exp Med. 1999. PMID: 10449520 Free PMC article.
-
Eosinophils and Th2 immunity: contemporary insights.Immunol Cell Biol. 2010 Mar-Apr;88(3):250-6. doi: 10.1038/icb.2009.115. Epub 2010 Jan 12. Immunol Cell Biol. 2010. PMID: 20065995 Free PMC article. Review.
-
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands.Front Immunol. 2017 Apr 28;8:510. doi: 10.3389/fimmu.2017.00510. eCollection 2017. Front Immunol. 2017. PMID: 28503177 Free PMC article.
-
A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro.Am J Pathol. 1990 Jul;137(1):27-41. Am J Pathol. 1990. PMID: 2196816 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials